News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2023 Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV Todd Neale November 17, 2023
News Conference News AHA 2022 IRONMAN Misses but Lends Support to IV Iron Repletion in HF Shelley Wood November 05, 2022
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Conference News AHA 2020 EARLY-AF: First-line Ablation Beats Meds for Recent Paroxysmal A-fib Shelley Wood November 16, 2020
News Conference News AHA 2020 When PCI Decisions Ignore FFR Results, Patients Pay a Price Caitlin E. Cox November 14, 2020
News Conference News AHA 2019 Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY Yael L. Maxwell November 16, 2019
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Conference News AHA 2016 Subclinical A-fib Common in Older, Asymptomatic Patients Todd Neale November 18, 2016
News Conference News AHA 2016 Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery Michael O'Riordan November 15, 2016
News Conference News AHA 2014 FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes November 16, 2014
News Conference News AHA 2013 French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients Yael L. Maxwell November 20, 2013